Litigation for JANUVIA
✉ Email this page to a colleague
US Court Litigation for JANUVIA
Patent | Case Name | Docket | Date Filed | Date Terminated | Cause | Court | Jury Demand | Link To Docket |
---|---|---|---|---|---|---|---|---|
6,699,871 | Merck Sharp & Dohme, LLC v. Mylan Pharmaceuticals Inc. | ⤷ Sign Up | 2019-05-02 | 2023-05-02 | 35:271 Patent Infringement | District Court, N.D. West Virginia | None | ⤷ Sign Up |
6,699,871 | TAKEDA PHARMACEUTICAL COMPANY LTD. v. TORRENT PHARMACEUTICALS LTD. | ⤷ Sign Up | 2017-05-05 | 2020-02-13 | 35:145 Patent Infringement | District Court, D. New Jersey | None | ⤷ Sign Up |
6,699,871 | ⤷ Sign Up | ⤷ Sign Up | 2021-07-09 | 2022-09-29 | Court of Appeals for the Federal Circuit | ⤷ Sign Up | ||
6,699,871 | Merck Sharp & Dohme, LLC v. Mylan Pharmaceuticals Inc. | ⤷ Sign Up | 2022-10-05 | 2023-05-11 | Court of Appeals for the Federal Circuit | ⤷ Sign Up | ||
>Patent | >Case Name | >Docket | >Date Filed | >Date Terminated | >Cause | >Court | >Jury Demand | >Link To Docket |
Patent Trial and Appeal Board Cases for JANUVIA
Patent | Petitioner | Status | Filing Date | Accorded Filing Date | Patent Owner | Trial Type | Trial Number | Decision Date | Inventor | Document Download |
---|---|---|---|---|---|---|---|---|---|---|
7,326,708 | Mylan Pharmaceuticals, Inc. | ⤷ Sign Up | 2019-10-30 | 11-14-2019 | Inter partes review | ⤷ Sign Up | 05-12-2020 | ⤷ Sign Up | ||
7,326,708 | Teva Pharmaceuticals USA, Inc. | ⤷ Sign Up | 2020-06-10 | 06-10-2020 | Cypes et al | Inter partes review | ⤷ Sign Up | 09-01-2020 | ⤷ Sign Up | |
7,326,708 | Dr. Reddy's Laboratories, Inc. et al. | ⤷ Sign Up | 2020-06-11 | 06-11-2020 | Inter partes review | ⤷ Sign Up | 09-01-2020 | ⤷ Sign Up | ||
7,326,708 | Sun Pharmaceutical Industries Ltd. et al. | ⤷ Sign Up | 2020-06-12 | 06-12-2020 | Inter partes review | ⤷ Sign Up | 09-01-2020 | ⤷ Sign Up | ||
>Patent | >Petitioner | >Status | >Filing Date | >Accorded Filing Date | >Patent Owner | >Trial Type | >Trial Number | >Decision Date | >Inventor | >Document Download |